In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer’s Disease
Alzheimer’s disease (AD) is caused by the hyperphosphorylation of Tau protein aggregation. FKBP52 (FK506 binding protein 52) has been found to inhibit Tau protein aggregation. This study found six different kinds of anthocyanins that have high binding potential. After analyzing the docking positions...
Main Authors: | Tzu-Chieh Hung, Tung-Ti Chang, Ming-Jen Fan, Cheng-Chun Lee, Calvin Yu-Chian Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/450592 |
Similar Items
-
Role of FKBP51 and FKBP52 in Glucocorticoid Receptor Regulated Metabolism
by: Warrier, Manya
Published: (2008) -
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
by: Nadia R. Zgajnar, et al.
Published: (2019-02-01) -
ID4 and FKBP52 Interaction Regulates Androgen Receptor Activity: Mechanistic Insight
by: Joshi, Jugal Bharat
Published: (2016) -
FKBP52-Progesterone Receptor Signaling During Pregnancy
by: Tranguch, Susanne
Published: (2007) -
Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila.
by: Reiko Sanokawa-Akakura, et al.
Published: (2010-01-01)